Clinical trial

A Study to Compare Subject Comfort During and After Injections With the Study…

NCT00417469 · Genzyme, a Sanofi Company, Industry · Completed

Key facts

NCT number NCT00417469
Title A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
Official title A Single-Blind, Randomized, Single-Center Evaluation of Procedural and Post Procedural Pain Experienced With Injections of NADG With Lidocaine Injectable Gel as Compared to Captique® Injectable Gel in Subjects Undergoing Cutaneous Correction of Nasolabial Folds
Lead sponsor Genzyme, a Sanofi Company, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Facial Wrinkles
Intervention type Device
Interventions NADGL
Enrollment 45
Start date Jan 1, 2007
Completion Feb 1, 2007
First posted Jan 1, 2007
Last update posted Mar 5, 2015
Countries United States

At a glance

  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies